Orphan designation: Heterologous human adult liver-derived stem cells Treatment of Crigler-Najjar syndrome, 29/11/2007 Positive

Orphan designation: Heterologous human adult liver-derived progenitor cells Treatment of hyperargininaemia, 17/07/2013 Positive

Orphan designation: Heterologous human adult liver-derived progenitor cells Treatment of carbamoyl-phosphate synthase-1 deficiency, 17/07/2013 Positive

Orphan designation: Heterologous human adult liver-derived progenitor cells Treatment of citrullinaemia type 2, 17/08/2013 Positive

Orphan designation: Heterologous human adult liver-derived progenitor cells Treatment of N-acetylglutamate synthetase (NAGS) deficiency, 17/07/2013 Positive

Human medicines European public assessment report (EPAR): Siklos, hydroxycarbamide, Date of authorisation: 29/06/2007, Revision: 26, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Versican Plus Pi/L4R, canine parainfluenza virus, leptospira and rabies virus, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Equip WNV (previously Duvaxyn WNV), vaccine to aid in prevention of West Nile virus, Status: Authorised

Agenda of the CHMP meeting 14-17 October 2024

Veterinary medicines European public assessment report (EPAR): Versican Plus DHPPi/L4R, live, attenuated Canine distemper virus, canine adenovirus, canine parvovirus, canine parainfluenza virus inactivated and Leptospira, Status: Authorised